SCHEMBL19361329

SCHEMBL19361329

CC(C)CCOC(=O)[C@@H](N)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ SLC7A5 Q01650 1/20 0.41
▸ CYP19A1 P11511 1/20 0.39
▸ CHRNB2 P17787 2/20 0.38
▸ CHRNA4 P43681 2/20 0.38
▸ CHRNB4 P30926 1/20 0.38
▸ CHRNA3 P32297 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ PKM P14618 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ DPP4 P27487 1/20 0.36
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25039128 1.00 CA12 (0.42) CA12CA1CA2CA9SLC7A5
SCHEMBL19387347 0.88 SLC7A5 (0.38) CA12CA1CA2CA9SLC7A5
SCHEMBL19387340 0.88 SLC7A5 (0.38) CA12CA1CA2CA9SLC7A5
SCHEMBL19750463 0.88 SLC7A5 (0.38) CA12CA1CA2CA9SLC7A5
SCHEMBL15623815 0.86 SLC7A5 (0.48) SLC7A5CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL26359428 0.86 SLC7A5 (0.48) SLC7A5CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL13224082 0.86 RARB (0.37) SLC7A5CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL18672811 0.86 RARB (0.37) SLC7A5CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL24159912 0.85 CYP19A1 (0.41) CA12CA1CA2CA9CYP19A1
SCHEMBL20919191 0.84 RARB (0.36) SLC7A5DPP4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170266172-A1 Compositions and Uses of Amidine Derivatives WILMINGTON TRUST, NATIONAL ASSOCIATION 2017-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170266172-A1 Compositions and Uses of Amidine Derivatives HRH3, HRH2, HRH1 CA12 2555/4885CA1 2772/4885CA2 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback